US approves updated Pfizer, Moderna shots targeting Omicron / Photo: Joseph Prezioso - AFP/File
CMSC
0.0500
Zürcher Nachrichten - US approves updated Pfizer, Moderna shots targeting Omicron
EUR
-
AED 4.207188
AFN 72.747127
ALL 94.522947
AMD 420.891414
ANG 2.051074
AOA 1051.654532
ARS 1676.580608
AUD 1.635534
AWG 2.064932
AZN 1.941136
BAM 1.952976
BBD 2.307307
BDT 140.496849
BGN 1.937062
BHD 0.432043
BIF 3416.05302
BMD 1.145594
BND 1.479014
BOB 7.909563
BRL 5.902669
BSD 1.145609
BTN 107.994816
BWP 15.568603
BYN 3.183079
BYR 22453.63325
BZD 2.303909
CAD 1.625282
CDF 2611.953355
CHF 0.925674
CLF 0.026247
CLP 1032.993657
CNY 7.755207
CNH 7.765681
COP 3949.78884
CRC 519.690857
CUC 1.145594
CUP 30.358229
CVE 110.105793
CZK 24.186002
DJF 203.99687
DKK 7.474568
DOP 66.960168
DZD 152.91815
EGP 57.161796
ERN 17.183903
ETB 181.324038
FJD 2.575008
FKP 0.865737
GBP 0.866957
GEL 3.036137
GGP 0.865737
GHS 12.819464
GIP 0.865737
GMD 84.204043
GNF 10036.029975
GTQ 8.731375
GYD 239.433792
HKD 8.980611
HNL 30.644771
HRK 7.532618
HTG 149.64229
HUF 351.691461
IDR 20424.500704
ILS 3.39594
IMP 0.865737
INR 108.218146
IQD 1499.431902
IRR 1575191.108326
ISK 144.063115
JEP 0.865737
JMD 181.012323
JOD 0.812188
JPY 185.201811
KES 148.251191
KGS 100.181797
KHR 4594.247018
KMF 492.00917
KPW 1031.034581
KRW 1758.377232
KWD 0.352866
KYD 0.954615
KZT 559.062556
LAK 25299.72938
LBP 102584.781028
LKR 382.329231
LRD 208.494155
LSL 18.890698
LTL 3.38264
LVL 0.692958
LYD 7.30659
MAD 10.66428
MDL 20.230789
MGA 4823.08884
MKD 61.604269
MMK 2405.150558
MNT 4101.708672
MOP 9.240938
MRU 45.719803
MUR 54.770554
MVR 17.699977
MWK 1986.418361
MXN 19.868097
MYR 4.757077
MZN 73.215224
NAD 18.890698
NGN 1561.913565
NIO 42.154924
NOK 11.107274
NPR 172.793212
NZD 1.999279
OMR 0.440465
PAB 1.144645
PEN 3.873499
PGK 5.021013
PHP 70.015239
PKR 318.665757
PLN 4.257627
PYG 7034.753905
QAR 4.172567
RON 5.238
RSD 117.355676
RUB 83.629808
RWF 1678.201706
SAR 4.300204
SBD 9.235115
SCR 16.954866
SDG 687.92911
SEK 10.989107
SGD 1.480634
SHP 0.855301
SLE 28.353755
SLL 24022.527792
SOS 654.710539
SRD 42.848065
STD 23711.473192
STN 24.485435
SVC 10.023906
SYP 126.624856
SZL 18.885601
THB 37.696321
TJS 10.61615
TMT 4.009577
TND 3.382309
TOP 2.758315
TRY 53.226229
TTD 7.768311
TWD 36.26834
TZS 3008.880825
UAH 51.463337
UGX 4165.976222
USD 1.145594
UYU 45.763828
UZS 13792.057424
VES 694.954452
VND 30152.021793
VUV 135.332323
WST 3.152438
XAF 655.56703
XAG 0.017228
XAU 0.000273
XCD 3.096023
XCG 2.064572
XDR 0.815308
XOF 655.561311
XPF 119.331742
YER 273.342751
ZAR 18.821412
ZMK 10311.709535
ZMW 20.534606
ZWL 368.88065
- Not just a hideout: Sahel forests provide base for jihadists
- Ageless Messi has World Cup scoring record in his sights
- Africa faces child surgery crisis as key anaesthesia runs out
- Trump-backed populist wins razor-tight Colombia vote, sparking protests
- J-Bay: S.Africa's surf mecca missing out on the global tour
- 'Progress', say mediators, after Iran-US talks towards ending war
- Key points from the first round of Iran-US talks
- European countries close schools, cancel trains as heatwave set to intensify
- Crude prices drop, most stocks rise on 'positive' US-Iran talks
- 'Progress', say mediators, after Iran-US talks on ending war
US approves updated Pfizer, Moderna shots targeting Omicron
US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.
The two updated booster shots aimed at providing "better protection against Covid-19 caused by the Omicron variant" are approved for people age 12 and above for the Pfizer shot and 18 and older for Moderna, the Food and Drug Administration (FDA) said in a statement.
This new generation of anti-Covid vaccines targets both the original strain of coronavirus and the BA.4 and BA.5 lineages, the subvariants of Omicron that are causing the most cases in the United States and which the FDA predicts will circulate in the coming months.
Earlier this summer the US health department announced it had purchased 105 million doses from Pfizer and 66 million from Moderna for use over the fall and winter.
The vaccines have yet to be recommended by the Centers for Disease Control and Prevention, the nation's health protection agency. But an independent panel of experts is scheduled to be convened by the CDC on Thursday to discuss the updates.
CDC director Rochelle Walensky will be in charge of giving the final green light.
The new versions of the vaccines could potentially be available in the United States as early as next week.
"Receiving a booster that specifically targets the Omicron BA.4/.5 variant, currently the most prevalent strain of SARS-CoV-2, is an important public health measure that people can take to help protect themselves, especially as we head into a season filled with indoor gatherings," Moderna chief executive Stephane Bancel said in a statement.
The vaccines currently in circulation target the initial strain of the virus that first appeared in Wuhan, China. But they have gradually proven to be less effective against the variants that have appeared over time, due to rapid evolution of the virus.
In contrast to the Alpha and Delta variants, which eventually waned, Omicron and its subvariants have come to dominate infections worldwide in 2022.
Pfizer and Moderna have also filed for approval of their updated vaccines with the European Medicines Agency.
J.Hasler--NZN
